---
figid: PMC3708595__nihms474972f4
figtitle: Mutational Landscape of Adenoid Cystic Carcinoma
organisms:
- NA
pmcid: PMC3708595
filename: nihms474972f4.jpg
figlink: /pmc/articles/PMC3708595/figure/F4/
number: F4
caption: Alterations are defined by somatic mutations, homozygous deletions, high-level
  focal amplifications, and structural variants validated by FISH or PCR. Frequencies
  are expressed as a percentage of all cases. Red background denotes activating alteration,
  blue background denotes inactivating alteration, white background denotes numerous
  alterations, and purple background denotes alteration of unclear significance. Interactions
  based upon IPA or Pathway Commons. (a). Epigenetic modification. (b). DNA damage/checkpoint
  signaling pathway. (c). MYB/MYC signaling pathway, with fusion denoted by recurrent
  t(6;9) translocation between MYB and NFIB. (d). FGF/IGF/PI3K signaling pathway.
  (e). Notch signaling pathway.
papertitle: The Mutational Landscape of Adenoid Cystic Carcinoma.
reftext: Allen S. Ho, et al. Nat Genet. 2013 Jul;45(7):791-798.
year: '2013'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9006618
figid_alias: PMC3708595__F4
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC3708595__F4
ndex: ee744723-df10-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3708595__nihms474972f4.html
  '@type': Dataset
  description: Alterations are defined by somatic mutations, homozygous deletions,
    high-level focal amplifications, and structural variants validated by FISH or
    PCR. Frequencies are expressed as a percentage of all cases. Red background denotes
    activating alteration, blue background denotes inactivating alteration, white
    background denotes numerous alterations, and purple background denotes alteration
    of unclear significance. Interactions based upon IPA or Pathway Commons. (a).
    Epigenetic modification. (b). DNA damage/checkpoint signaling pathway. (c). MYB/MYC
    signaling pathway, with fusion denoted by recurrent t(6;9) translocation between
    MYB and NFIB. (d). FGF/IGF/PI3K signaling pathway. (e). Notch signaling pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SMARCA2
  - ARID1A
  - SMARCE1
  - ATRX
  - SRCAP
  - CREBBP
  - ATM
  - PRKDC
  - H1-0
  - H1-1
  - H1-2
  - H1-3
  - H1-4
  - H1-5
  - H1-6
  - H1-7
  - H1-8
  - H1-10
  - .na.character
  - H2AB1
  - H2AJ
  - H2AZ2
  - H2AX
  - MACROH2A1
  - MACROH2A2
  - H2AZ1
  - H2AC1
  - H2AC6
  - H2AC7
  - H2AC12
  - H2AC14
  - H2AC21
  - H2AC20
  - H2AC25
  - H2BC1
  - H2BC3
  - H2BC5
  - H2BC9
  - H2BC11
  - H2BC12
  - H2BC13
  - H2BC14
  - H2BC15
  - H2BC17
  - H2BC18
  - H2BC19P
  - H2BC20P
  - H2BC21
  - H2BC26
  - H2BC12L
  - H2BW2
  - H2BW1
  - H3-4
  - H3-5
  - H4C7
  - SETD2
  - EP300
  - MORF4L1
  - CMTR2
  - SMC1A
  - BRCA1
  - TP53
  - H2AC16
  - KMT2C
  - NSD1
  - BRD1
  - KAT6A
  - KANSL1
  - UHRF1
  - CHEK1
  - CHEK2
  - KDM6A
  - KDM6B
  - ARID4B
  - TLK1
  - CDK1
  - POLD1
  - BCORL1
  - BCOR
  - JMJD1C
  - WARS1
  - MYC
  - MYB
  - IGF1
  - FGF1
  - FGF2
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FGF10
  - FGF11
  - FGF12
  - FGF13
  - FGF14
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - NOTCH1
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - CNTN6
  - IL17RD
  - ERBIN
  - MYBL1
  - NFIB
  - FGFR4
  - INSRR
  - EGFR
  - ERBB2
  - ERBB3
  - ERBB4
  - DTX4
  - NCOR1
  - NCOR2
  - CEBPA
  - CEBPB
  - CEBPD
  - CEBPG
  - CEBPE
  - FOXP2
  - FBXW7
  - PTEN
  - HRAS
  - MYCN
  - MYCBP
  - MAML3
  - MAGI1
  - CNKSR3
  - AKT1
  - AKT2
  - AKT3
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MGA
  - MGAM
  - MAX
  - MAGI2
  - MAP2K2
  - Breast cancer
  - Cancer
  - Lung cancer
---
